LOB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
LOB is not a strong buy right now for a Beginner long-term investor, even with $50,000-$100,000 available. The stock is technically constructive and the fundamentals/news are supportive, but the current setup is more of a fair-value hold than an urgent long-term entry. Since you want a direct answer and are unwilling to wait for an ideal entry, my call is to hold off rather than buy aggressively at this level.
LOB is in a mild uptrend technically. MACD histogram is positive at 0.201, though it is contracting, which suggests momentum is still supportive but not accelerating. RSI_6 at 61.1 is neutral-to-bullish and does not indicate overbought conditions. The moving averages are aligned bullishly (SMA_5 > SMA_20 > SMA_200), which confirms a positive trend structure. Price at 41.05 is near the pivot at 40.19 and just below R1 at 41.844, so the stock is sitting near a short-term breakout zone rather than at a clear discount.
Recent news was constructive: Q1 2026 results showed strong performance with $1.37 billion in loans originated, and the company reported a nearly 40% increase in stock price over the past year. A new Chief Accounting Officer was also appointed, which supports financial management stability. Analyst commentary remains broadly positive, with TD Cowen maintaining Buy and Keefe Bruyette maintaining Outperform. Technical trend is also supportive with bullish moving averages and a positive MACD.
Recent director selling is a modest negative signal: William L. III Williams indirectly sold 8,400 shares for about $336,000, trimming his stake by 0.6%. Piper Sandler still rates the stock Neutral and only raised its target to $41, which is basically at the current price, suggesting limited near-term upside from that view. The MACD histogram is positive but contracting, so momentum is not strengthening. There is also no strong proprietary trading signal today from AI Stock Picker or SwingMax.
Latest quarter: Q1 2026. The company reported strong operating performance, highlighted by $1.37 billion in loans originated and a core earnings beat tied to net interest income and provision performance. News also notes improving credit stability and a stabilizing credit outlook. Overall, the latest quarter looks healthy and growth-oriented, especially in lending activity, which is a positive sign for a long-term investor.
Analyst sentiment is mildly positive overall. TD Cowen lowered its target to $47 from $51 but kept a Buy rating, citing firm fundamentals and a stabilizing credit outlook. Piper Sandler raised its target slightly to $41 from $40 but kept a Neutral rating, implying limited upside from current levels. Keefe Bruyette lowered its target to $42 from $44 while keeping Outperform. Wall Street’s view is mixed-to-bullish: the pros like the fundamentals, but the spread of targets and one Neutral rating suggest the stock is fairly priced rather than deeply undervalued.
